No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Brentuximab Vedotin
-
Hodgkin Disease / complications*
-
Hodgkin Disease / drug therapy
-
Hodgkin Disease / pathology
-
Humans
-
Immunoconjugates / adverse effects*
-
Immunoconjugates / therapeutic use
-
Male
-
Peripheral Nervous System Diseases / diagnosis
-
Peripheral Nervous System Diseases / drug therapy
-
Peripheral Nervous System Diseases / etiology*
-
Young Adult
Substances
-
Antineoplastic Agents
-
Immunoconjugates
-
Brentuximab Vedotin